In patients with pancreatic cancer from a randomized phase III RTOG 9704 study, hENT1 expression was associated with increased overall survival (OS) and disease-free survival in patients who received adjuvant gemcitabine chemotherapy, but not in those who received 5-fluorouracil [10]. Here, SLC29A1 is linked to pancreatic neoplasm.